OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600995 China Southern Power Grid Energy Storage
- 9.63
- +0.08+0.84%
Trading Apr 1 13:37 CST
30.78BMarket Cap27.36P/E (TTM)
9.71High9.55Low80.54KlotVolume9.55Open9.55Pre Close77.82MTurnover0.73%Turnover Ratio27.36P/E (Static)3.20BShares12.1252wk High1.44P/B10.68BFloat Cap8.5952wk Low10.51Limit Up1.11BShs Float22.01Historical High8.60Limit Down1.68%Amplitude-0.33Historical Low0.13Dividend TTM9.66Avg Price35.33KlotAsk1.39%Div YieldTTM100Lot Size44.71KlotBid
China Southern Power Grid Energy Storage Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 9.67%6.17B | 11.12%4.52B | 1.76%2.91B | -5.96%1.32B | -31.85%5.63B | -36.37%4.07B | -31.07%2.86B | -26.11%1.41B | 0.64%8.26B | 5.66%6.39B |
| Operating revenue | 9.67%6.17B | 11.12%4.52B | 1.76%2.91B | -5.96%1.32B | -31.85%5.63B | -36.37%4.07B | -31.07%2.86B | -26.11%1.41B | 0.64%8.26B | 5.66%6.39B |
| Other operating revenue | 55.51%89.38M | ---- | -14.37%15.05M | ---- | -16.00%57.48M | ---- | -44.62%17.57M | ---- | -4.49%68.43M | ---- |
| Total operating cost | 4.50%4.34B | 2.07%2.91B | 3.59%1.9B | 4.15%885.78M | -26.71%4.15B | -33.66%2.85B | -32.18%1.84B | -32.35%850.47M | -13.47%5.66B | -4.59%4.29B |
| Operating cost | 7.18%3.26B | 5.29%2.2B | 6.17%1.45B | 9.20%672.72M | -28.69%3.04B | -36.69%2.09B | -35.51%1.36B | -37.08%616.02M | -19.33%4.27B | -12.15%3.31B |
| Operating tax surcharges | -14.77%125.69M | -20.27%86.72M | 10.28%50.04M | 9.15%20.98M | 15.99%147.47M | 5.55%108.77M | 0.98%45.38M | 4.50%19.22M | 33.18%127.14M | 96.39%103.05M |
| Operating expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35.14%3.71M | 0.94%3.69M |
| Administration expense | -5.74%454.46M | -5.50%273.29M | -3.76%180.35M | -8.10%82.83M | -13.77%482.13M | -21.74%289.2M | -16.74%187.39M | -16.35%90.13M | -18.58%559.11M | 18.81%369.54M |
| Financial expense | -2.89%438.35M | -4.75%329.35M | -6.78%218.19M | -12.11%109.09M | -30.21%451.38M | -29.54%345.77M | -26.68%234.07M | -17.40%124.12M | 49.15%646.73M | 49.56%490.74M |
| -Interest expense (Financial expense) | -8.19%479.03M | -6.15%358.94M | -5.68%241.4M | 0.41%120.3M | -22.46%521.75M | -25.04%382.45M | -23.54%255.94M | -17.45%119.81M | 49.85%672.91M | 49.24%510.24M |
| -Interest Income (Financial expense) | 46.47%-38.02M | 27.83%-29.73M | 5.51%-23.04M | -107.12%-12M | -123.33%-71.02M | -99.21%-41.19M | -77.09%-24.38M | 10.53%-5.79M | -51.29%-31.8M | -52.81%-20.67M |
| Research and development | 118.08%56.99M | 23.86%13.31M | 1.37%7.45M | -84.28%153.02K | -55.19%26.13M | -44.79%10.74M | 96.01%7.35M | 146.33%973.41K | 78.78%58.32M | -51.61%19.46M |
| Credit Impairment Loss | -8.71%2.28M | -76.22%1.02M | -43.05%803.74K | -134.73%-96.06K | 87.39%2.5M | 47.75%4.29M | -79.34%1.41M | -72.51%276.56K | -74.44%1.33M | 1,049.11%2.9M |
| Asset Impairment Loss | -921.48%-11.62K | -450.38%-6.52K | -450.38%-6.52K | ---- | 100.03%1.41K | --1.86K | --1.86K | --1.86K | -104.52%-5.44M | ---- |
| Other net revenue | 86.20%42.71M | 35.41%27.69M | -47.24%7.6M | -50.06%2.72M | -15.15%22.94M | -16.72%20.45M | -38.33%14.41M | -47.81%5.44M | -92.13%27.04M | -26.23%24.55M |
| Fair value change income | -40.60%734.32K | ---- | ---- | ---- | 146.50%1.24M | ---- | ---- | ---- | --501.48K | ---- |
| Invest income | 147.09%21.25M | 216.10%24.68M | 13.93%5.53M | 7.60%1.78M | -7.25%8.6M | -10.61%7.81M | -19.44%4.86M | 52.97%1.65M | -63.67%9.27M | -62.80%8.73M |
| -Including: Investment income associates | 102.54%17.06M | 223.76%24.63M | 17.73%5.48M | 18.93%1.73M | -9.07%8.43M | -12.91%7.61M | -22.77%4.66M | 34.39%1.45M | -63.70%9.27M | -62.80%8.73M |
| Asset deal income | 1,374.60%15.75M | 27.25%231.89K | -45.03%100.85K | ---- | -88.57%1.07M | -97.34%182.23K | -96.75%183.48K | -96.41%203.27K | -94.80%9.35M | 2,604,246.43%6.84M |
| Other revenue | -71.61%2.71M | -78.42%1.76M | -85.29%1.17M | -68.68%1.03M | -20.65%9.54M | 34.46%8.17M | 63.86%7.95M | 23.46%3.3M | -2.49%12.02M | -45.16%6.07M |
| Operating profit | 25.12%1.88B | 32.34%1.64B | -2.17%1.01B | -21.65%441.64M | -42.79%1.5B | -41.63%1.24B | -29.14%1.04B | -14.58%563.65M | 30.81%2.62B | 34.16%2.12B |
| Add:Non operating Income | -14.45%5.82M | 11.97%2.37M | 66.06%1.63M | 168.00%469.29K | 64.85%6.8M | -38.80%2.11M | -50.47%982.11K | -47.99%175.11K | -62.42%4.13M | 6.63%3.46M |
| Less:Non operating expense | 257.70%53.86M | 50.82%6.54M | 92.37%3.39M | 230.44%2.41M | -22.16%15.06M | -65.11%4.34M | -43.04%1.76M | 331.24%729.69K | 37.28%19.34M | 269.99%12.42M |
| Total profit | 22.60%1.83B | 32.24%1.64B | -2.27%1.01B | -21.91%439.7M | -42.77%1.49B | -41.48%1.24B | -29.14%1.04B | -14.68%563.1M | 30.25%2.61B | 33.60%2.11B |
| Less:Income tax cost | 61.68%398.92M | 49.35%350.93M | 19.21%231.21M | -21.01%87.1M | -52.70%246.74M | -47.15%234.97M | -37.71%193.95M | -24.30%110.27M | 34.07%521.59M | 49.53%444.61M |
| Net profit | 14.86%1.43B | 28.22%1.28B | -7.21%781.83M | -22.14%352.6M | -40.29%1.25B | -39.97%1B | -26.82%842.58M | -11.96%452.83M | 29.33%2.09B | 29.92%1.67B |
| Net profit from continuing operation | 14.86%1.43B | 28.22%1.28B | -7.21%781.83M | -22.14%352.6M | -40.29%1.25B | -39.97%1B | -26.82%842.58M | -11.96%452.83M | 29.33%2.09B | 29.92%1.67B |
| Less:Minority Profit | 31.05%305.07M | 30.95%239.03M | 3.75%155.61M | -7.41%67.32M | -45.14%232.78M | -47.71%182.54M | -29.11%149.97M | -26.11%72.72M | 15.85%424.35M | 18.66%349.1M |
| Net profit of parent company owners | 11.14%1.13B | 27.62%1.05B | -9.58%626.22M | -24.95%285.27M | -39.05%1.01B | -37.93%818.98M | -26.30%692.6M | -8.61%380.12M | 33.28%1.66B | 33.26%1.32B |
| Earning per share | ||||||||||
| Basic earning per share | 9.37%0.35 | 26.92%0.33 | -9.09%0.2 | -25.00%0.09 | -50.00%0.32 | -49.02%0.26 | -40.54%0.22 | -25.00%0.12 | 30.61%0.64 | 30.77%0.51 |
| Diluted earning per share | 9.37%0.35 | 26.92%0.33 | -9.09%0.2 | -25.00%0.09 | -50.00%0.32 | -49.02%0.26 | -40.54%0.22 | -25.00%0.12 | 30.61%0.64 | 30.77%0.51 |
| Other composite income | -1,287.82%-232.8M | -1,805.77%-16.77M | 100.01%920.56 | 920.56 | -103.09%-880.21K | -8.39M | ||||
| Other composite income of parent company owners | -1,377.91%-229.61M | ---- | ---- | ---- | -1,503.48%-15.54M | 100.01%497.1 | --497.1 | ---- | -103.27%-968.89K | ---7.15M |
| Other composite income of minority owners | -158.04%-3.2M | ---- | ---- | ---- | -1,496.96%-1.24M | 100.03%423.46 | --423.46 | ---- | 107.94%88.68K | ---1.23M |
| Total composite income | -2.51%1.2B | 28.22%1.28B | -7.21%781.83M | -22.14%352.6M | -41.07%1.23B | -39.67%1B | -26.82%842.58M | -11.96%452.83M | 27.03%2.09B | 29.26%1.66B |
| Total composite income of parent company owners | -10.14%896.87M | 27.62%1.05B | -9.58%626.22M | -24.95%285.27M | -39.95%998.03M | -37.59%818.99M | -26.30%692.6M | -8.61%380.12M | 30.12%1.66B | 32.54%1.31B |
| Total composite income of minority owners | 30.38%301.88M | 30.95%239.03M | 3.75%155.61M | -7.41%67.32M | -45.45%231.54M | -47.53%182.54M | -29.11%149.97M | -26.11%72.72M | 16.23%424.43M | 18.24%347.87M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.